| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/11/2003 | US20030226755 Apparatus and method for performing microfluidic manipulations for chemical analysis and synthesis |
| 12/11/2003 | US20030226753 Apparatus and method for performing microfluidic manipulations for chemical analysis and synthesis |
| 12/11/2003 | US20030226604 Method of fabrication of a microfluidic device |
| 12/11/2003 | US20030226404 Apparatus and method for testing stiffness of articles |
| 12/11/2003 | US20030226397 Directional coupler sensor |
| 12/11/2003 | US20030226396 Water cut rate of change analytic method |
| 12/11/2003 | US20030226393 Apparatus for measuring green-speed |
| 12/11/2003 | DE20315345U1 Reagent mixture for determination of albumen in biological fluid, useful for early diagnosis of e.g. kidney disease, includes polysaccharide, disaccharide and boric acid |
| 12/11/2003 | DE20309099U1 Device for the technical conversion of air screening data and reproduction of odorous environments comprises a module with horizontally arranged cartridges charged with liquid, liquid bound in granules, gaseous or solid base materials |
| 12/11/2003 | DE20220620U1 Microtitration plate has a transparent base plate with an optically transparent and electrically conductive coating, supporting a multiple-wave superstructure to define the cavities, held by a release bond |
| 12/11/2003 | CA2736974A1 Tumour-associated peptides that bind to mhc molecules |
| 12/11/2003 | CA2736972A1 Tumour-associated peptides that bind to mhc molecules |
| 12/11/2003 | CA2736926A1 Tumour associated peptides that bind to mhc molecules |
| 12/11/2003 | CA2736921A1 Tumour-associated peptides that bind to mhc molecules |
| 12/11/2003 | CA2510406A1 Method of detecting gene polymorphism |
| 12/11/2003 | CA2492631A1 Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood |
| 12/11/2003 | CA2491420A1 Rb1 gene induced protein (rb1cc1) and gene |
| 12/11/2003 | CA2488568A1 Methods of diagnosing and treating diabetes and insulin resistance |
| 12/11/2003 | CA2488547A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 12/11/2003 | CA2488539A1 Novel proteins and nucleic acids encoding same |
| 12/11/2003 | CA2488441A1 Synthetic antibody phage libraries |
| 12/11/2003 | CA2488284A1 Cancer-linked gene as target for chemotherapy |
| 12/11/2003 | CA2488048A1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 12/11/2003 | CA2488012A1 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 12/11/2003 | CA2487954A1 Methods of detecting target molecules and molecular interactions |
| 12/11/2003 | CA2487944A1 Biomolecular kinetics method using a flow-through microarray |
| 12/11/2003 | CA2487939A1 Semaphorin-like proteins and methods of using same |
| 12/11/2003 | CA2487936A1 Method for high-throughput integrated chemical and biochemical reactions |
| 12/11/2003 | CA2487929A1 High throughput cellular response assay using microarrays |
| 12/11/2003 | CA2487928A1 Pthrp-based prediction and diagnosis of bone disease |
| 12/11/2003 | CA2487895A1 Defensins: use as antiviral agents |
| 12/11/2003 | CA2487792A1 Device and method of use for detection and characterization of pathogens and biological materials |
| 12/11/2003 | CA2487765A1 Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment |
| 12/11/2003 | CA2487730A1 Sgk and nedd used as diagnostic and therapeutic targets |
| 12/11/2003 | CA2487719A1 Measuring nitric oxide in blood gases and treatments based thereon |
| 12/11/2003 | CA2487636A1 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 12/11/2003 | CA2487513A1 Improved receptor detection |
| 12/11/2003 | CA2487350A1 Cartridge arrangement, fluid analyzer arrangement, and methods |
| 12/11/2003 | CA2487314A1 Methods for quantitative proteome analysis of glycoproteins |
| 12/11/2003 | CA2487137A1 Tumour-associated peptides that bind to mhc molecules |
| 12/11/2003 | CA2486911A1 Method of screening groups of radioactive molecules and applications thereof |
| 12/11/2003 | CA2486676A1 Polyol-modified silanes as precursors for silica |
| 12/11/2003 | CA2486548A1 Animal model for toxicology and dose prediction |
| 12/11/2003 | CA2485942A1 Universal biosensor and methods of use |
| 12/11/2003 | CA2485653A1 Human 5-ht7 receptor promoter sequence |
| 12/11/2003 | CA2484629A1 Electrofusion of cells and apparatus therefore |
| 12/11/2003 | CA2484627A1 Cell recovery |
| 12/11/2003 | CA2482957A1 Assay for glycosylated proteins |
| 12/11/2003 | CA2480326A1 Knockout mice and their use |
| 12/10/2003 | EP1369698A1 Diagnostics and therapeutics for diseases associated with somatostatin receptor 5 (SSTR5) |
| 12/10/2003 | EP1369697A1 Diagnostics and therapeutics for diseases associated with somatostatin receptor 4 (SSTR4) |
| 12/10/2003 | EP1369696A1 Diagnostics and therapeutics for diseases associated with somatostatin receptor 3 (SSTR3) |
| 12/10/2003 | EP1369695A1 Method for identifying type-I interferon responsive MS patients by determining TRAIL expression |
| 12/10/2003 | EP1369694A1 Method for discrimination of metaplasias from neoplastic or preneoplastic lesions |
| 12/10/2003 | EP1369693A1 Method for the diagnosis of sepsis and the control of donor blood with the help of anti-asialo ganglioside antibodies |
| 12/10/2003 | EP1369692A2 Sensor surface |
| 12/10/2003 | EP1369691A1 Device and method utilizing arrays of structures for analyte capture |
| 12/10/2003 | EP1369690A1 Immobilised G-protein coupled receptors on an artificial lipid membrane of a liquid chromatography stationary phase and use thereof for screening |
| 12/10/2003 | EP1369689A1 Immunoassay method and immunoassay reagent kit to be used therein |
| 12/10/2003 | EP1369688A2 Analyte testing device |
| 12/10/2003 | EP1369687A1 Biosensor |
| 12/10/2003 | EP1369686A2 Analyte concentration determination meters and methods of using the same |
| 12/10/2003 | EP1369684A1 Quantitative analyzing method and quantitative analyzer using sensor |
| 12/10/2003 | EP1369681A1 Hologram used as a sensor |
| 12/10/2003 | EP1369496A2 Method of making random array of microspheres using enzyme digestion |
| 12/10/2003 | EP1369494A2 Method for ordering macromolecules by means of a moving meniscus and uses thereof |
| 12/10/2003 | EP1369493A1 Quantitative determination method for the degree of methylation of cytosines in CpG positions |
| 12/10/2003 | EP1369491A1 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 12/10/2003 | EP1369479A1 Novel cell adhesion molecule specific to activated leukocyte |
| 12/10/2003 | EP1369478A1 Novel scavenger receptor class a protein |
| 12/10/2003 | EP1369473A2 Automated cassete module for an apparatus for conducting immunoassays and use thereof |
| 12/10/2003 | EP1369427A2 HIV-3 retrovirus strains and their use |
| 12/10/2003 | EP1369382A2 Carbon monoxide removal from reformate gas |
| 12/10/2003 | EP1369128A1 Inhibitors of glycoprotein VI and their therapeutic use |
| 12/10/2003 | EP1369116A1 Oxalatoplatin and 5-fluorouracil for combination therapy of cancer |
| 12/10/2003 | EP1369077A2 Imaging system for detecting diseased tissue using native fluorescence in the gastrointestinal or respiratory tract |
| 12/10/2003 | EP1368841A1 Multi-color organic display with light-emitting layers formed by flexographic pinting |
| 12/10/2003 | EP1368775A2 Identifying antigen clusters for monitoring a global state of an immune system |
| 12/10/2003 | EP1368663A2 Novel reagents for detecting cannabinoids |
| 12/10/2003 | EP1368662A2 Method for detection of the presence of prion proteins |
| 12/10/2003 | EP1368661A2 Monitoring soluable endothelial protein c receptor levels in anticoagulant therapy |
| 12/10/2003 | EP1368660A2 Assay |
| 12/10/2003 | EP1368659A2 Subunit vaccines with a2 supermotifs |
| 12/10/2003 | EP1368658A2 A kit and method for detecting food allergies |
| 12/10/2003 | EP1368657A1 A kit and method for detecting fecal parasites |
| 12/10/2003 | EP1368656A2 Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith |
| 12/10/2003 | EP1368655A2 Distinguishing molecular forms |
| 12/10/2003 | EP1368654A1 Multiplex protein interaction determinations using glutathione-gst binding |
| 12/10/2003 | EP1368653A1 Methods to increase the capacity of high content cell-based screening assays |
| 12/10/2003 | EP1368652A2 Improved method for detecting cells |
| 12/10/2003 | EP1368651A2 Methods and material for evaluating cardiovascular conditions |
| 12/10/2003 | EP1368650A1 Immunological detection of prostate diseases and prostasome-related conditions |
| 12/10/2003 | EP1368649A2 Electrochemical test strip cards that include an integral dessicant |
| 12/10/2003 | EP1368648A2 Detection of compounds that modulate inflammatory responses |
| 12/10/2003 | EP1368647A2 Proteins, genes and their use for diagnosis and treatment of vascular response |
| 12/10/2003 | EP1368646A2 Method and apparatus for on-line monitoring of quality and/or condition of highly resistive fluids |
| 12/10/2003 | EP1368645A2 Method and apparatus for analyzing mixtures of gases |
| 12/10/2003 | EP1368644A2 ANTIBODIES SPECIFIC FOR UNGULATE PrP |
| 12/10/2003 | EP1368639A1 Device and method for automatically producing a thermal recoil response in nematodes |
| 12/10/2003 | EP1368638A2 Method and apparatus for improving the accuracy of noninvasive hematocrit measurements |